Logo image of BRYN.DE

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR

453.1  -7 (-1.52%)

Fundamental Rating

5

Taking everything into account, BRYN scores 5 out of 10 in our fundamental rating. BRYN was compared to 50 industry peers in the Financial Services industry. Both the profitability and the financial health of BRYN get a neutral evaluation. Nothing too spectacular is happening here. BRYN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BRYN was profitable.
BRYN had a positive operating cash flow in the past year.
BRYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BRYN had a positive operating cash flow.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

The Return On Assets of BRYN (7.71%) is better than 72.00% of its industry peers.
Looking at the Return On Equity, with a value of 13.70%, BRYN is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.68%, BRYN is doing good in the industry, outperforming 62.00% of the companies in the same industry.
BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is significantly below the industry average of 11.19%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.71%
ROE 13.7%
ROIC 4.68%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of BRYN (23.96%) is better than 70.00% of its industry peers.
In the last couple of years the Profit Margin of BRYN has declined.
BRYN's Operating Margin of 16.41% is fine compared to the rest of the industry. BRYN outperforms 66.00% of its industry peers.
In the last couple of years the Operating Margin of BRYN has grown nicely.
BRYN's Gross Margin of 16.21% is on the low side compared to the rest of the industry. BRYN is outperformed by 62.00% of its industry peers.
BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.41%
PM (TTM) 23.96%
GM 16.21%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
BRYN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BRYN has been reduced compared to 5 years ago.
The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.36, BRYN perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
BRYN has a debt to FCF ratio of 10.74. This is a negative value and a sign of low solvency as BRYN would need 10.74 years to pay back of all of its debts.
BRYN's Debt to FCF ratio of 10.74 is in line compared to the rest of the industry. BRYN outperforms 46.00% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that BRYN is not too dependend on debt financing.
BRYN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: BRYN outperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.74
Altman-Z 1.36
ROIC/WACC1.42
WACC3.29%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

A Current Ratio of 1.18 indicates that BRYN should not have too much problems paying its short term obligations.
BRYN's Current ratio of 1.18 is in line compared to the rest of the industry. BRYN outperforms 54.00% of its industry peers.
A Quick Ratio of 0.94 indicates that BRYN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, BRYN is doing worse than 64.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.94
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

4

3. Growth

3.1 Past

BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.98%, which is quite impressive.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 1.91% in the last year.
The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)27.98%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%71.86%
Revenue 1Y (TTM)1.91%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%1.65%

3.2 Future

Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.54% on average per year.
The Revenue is expected to grow by 0.14% on average over the next years.
EPS Next Y-6.68%
EPS Next 2Y-0.24%
EPS Next 3Y1.69%
EPS Next 5Y2.54%
Revenue Next Year0.6%
Revenue Next 2Y2.6%
Revenue Next 3Y0.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10K 20K 30K

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
Based on the Price/Earnings ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, BRYN is valued rather cheaply.
With a Price/Forward Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BRYN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.01
Fwd PE 0.02
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

98.00% of the companies in the same industry are more expensive than BRYN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA 1.02
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-0.24%
EPS Next 3Y1.69%

0

5. Dividend

5.1 Amount

BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (3/7/2025, 7:00:00 PM)

453.1

-7 (-1.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-22 2025-02-22/bmo
Earnings (Next)05-02 2025-05-02
Inst Owners33.43%
Inst Owner ChangeN/A
Ins Owners37.69%
Ins Owner ChangeN/A
Market Cap652.46M
Analysts80
Price Target503.62 (11.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.2%
Min EPS beat(2)-10.41%
Max EPS beat(2)42.8%
EPS beat(4)3
Avg EPS beat(4)16.14%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)12.04%
EPS beat(12)9
Avg EPS beat(12)10.27%
EPS beat(16)12
Avg EPS beat(16)9.92%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-7.69%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)0.24%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)5
Avg Revenue beat(12)-0.45%
Revenue beat(16)6
Avg Revenue beat(16)-0.71%
PT rev (1m)2.78%
PT rev (3m)2.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE 0.02
P/S 0
P/FCF 0.06
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 1.02
EPS(TTM)30389.34
EY6706.98%
EPS(NY)28360.49
Fwd EY6259.21%
FCF(TTM)7429.92
FCFY1639.8%
OCF(TTM)19567.5
OCFY4318.58%
SpS237579.06
BVpS415354.15
TBVpS338820
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 7.71%
ROE 13.7%
ROCE 5.79%
ROIC 4.68%
ROICexc 4.9%
ROICexgc 5.89%
OM 16.41%
PM (TTM) 23.96%
GM 16.21%
FCFM 3.13%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.74
Debt/EBITDA 1.69
Cap/Depr 147.62%
Cap/Sales 5.11%
Interest Coverage 12.34
Cash Conversion 41.46%
Profit Quality 13.05%
Current Ratio 1.18
Quick Ratio 0.94
Altman-Z 1.36
F-Score4
WACC3.29%
ROIC/WACC1.42
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.98%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%71.86%
EPS Next Y-6.68%
EPS Next 2Y-0.24%
EPS Next 3Y1.69%
EPS Next 5Y2.54%
Revenue 1Y (TTM)1.91%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%1.65%
Revenue Next Year0.6%
Revenue Next 2Y2.6%
Revenue Next 3Y0.14%
Revenue Next 5YN/A
EBIT growth 1Y26.05%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-37.82%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%